Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Dysport NG for moderate to severe glabellar lines
2014-003841-86Phase 3Completed
- Sponsor
- Ipsen
- Start
- Dec 2014
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of corabotase in glabellar furrowing (3 arms), sponsored by Ipsen. Primary endpoint: Proportion of responders at Day 29 during double-blind Cycle 1. Started Dec 2014; status: completed.
02
Drugs
corabotase
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on 2014-003841-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003841-86.